Acasti Pharma reported $9.94 in PE Price to Earnings for its fiscal quarter ending in March of 2021.





Pe Change Date
Acasti Pharma USD 9.94 0.08 Mar/2021
Addus HomeCare USD 18.91 0.17 Dec/2025
Amarin USD 91.05 88.3 Jun/2023
Knight Therapeutics CAD 91.09 0.73 Sep/2025
Option Care Health USD 25.07 3.02 Dec/2025
Organigram Holdings CAD 235 224.49 Sep/2025